FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912887446> ?p ?o ?g. }

• W2912887446 endingPage "175" @default.
• W2912887446 startingPage "167" @default.
• W2912887446 abstract "Background We compared time to treatment change (TC), viral suppression (VS) and change in CD4 + T-cell counts of first-line antiretroviral regimens (ART). Methods We analysed HIV treatment-naive adults from the Cohort of the Spanish HIV/AIDS Research Network (CoRIS) initiating the most commonly used ART regimens from September 2014 to November 2015. We used proportional hazards models on the sub-distribution hazard to estimate sub-distribution hazard ratios (sHR) for time to TC, logistic regression to estimate odds ratios (ORs) for VS (viral load <50 copies/ml), and linear regression to assess mean differences in CD4 + T-cell changes from ART initiation. Results Among 960 individuals, tenofovir (TDF)/emtricitabine (FTC)/rilpivirine (RPV) was the most frequently prescribed regimen (24.2%), followed by elvitegravir (EVG)/cobicistat (COBI)/TDF/FTC (22.8%), abacavir (ABC)/lamivudine (3TC)/dolutegavir (DTG; 17.4%), TDF/FTC+darunavir/ritonavir (DRV/r) or darunavir/cobicistat (DRV/c; 12.1%), TDF/FTC/efavirenz (EFV; 8.8%), TDF/FTC+raltegravir (RAL; 7.7%) and TDF/FTC+DTG (7.0%). Initiating ART with TDF/FTC+DRV/r or DRV/c (adjusted sHR: 2.96; 95% CI: 1.44, 6.08), TDF/FTC/EFV (2.18; 0.98, 4.82), TDF/FTC+RAL (2.37; 1.08, 5.22) and TDF/FTC+DTG (6.34; 3.18, 12.64) was associated with a higher risk of TC compared to ABC/3TC/DTG. At 24 weeks, VS was lower in TDF/FTC+DRV/r or DRV/c (adjusted OR: 0.37, 95% CI: 0.18, 0.74) compared with ABC/3TC/DTG, and CD4 + T-cell increase was lower in patients initiating with TDF/FTC/RPV (adjusted mean difference: −75.9, 95% CI: −130.6, −21.2) compared with those who did with ABC/3TC/DTG. Conclusions Time to TC, VS and change in CD4 + T-cell counts varies by initial regimen. These differences may be useful for making decision when initiating ART." @default.
• W2912887446 created "2019-02-21" @default.
• W2912887446 creator A5010962818 @default.
• W2912887446 creator A5011056386 @default.
• W2912887446 creator A5019618541 @default.
• W2912887446 creator A5029391761 @default.
• W2912887446 creator A5036522089 @default.
• W2912887446 creator A5041849450 @default.
• W2912887446 creator A5060181762 @default.
• W2912887446 creator A5064873706 @default.
• W2912887446 creator A5081346347 @default.
• W2912887446 date "2018-04-01" @default.
• W2912887446 modified "2023-10-08" @default.
• W2912887446 title "Durability of First-Line Antiretroviral Regimens in the era of Integrase Inhibitors: A Cohort of HIV-Positive Individuals in Spain, 2014–2015" @default.
• W2912887446 cites W1416208575 @default.
• W2912887446 cites W1974397412 @default.
• W2912887446 cites W1979097777 @default.
• W2912887446 cites W1985646480 @default.
• W2912887446 cites W1992655257 @default.
• W2912887446 cites W2019245817 @default.
• W2912887446 cites W2030038632 @default.
• W2912887446 cites W2068866500 @default.
• W2912887446 cites W2074919119 @default.
• W2912887446 cites W2075139859 @default.
• W2912887446 cites W2108676219 @default.
• W2912887446 cites W2120729896 @default.
• W2912887446 cites W2399191822 @default.
• W2912887446 cites W2556153964 @default.
• W2912887446 cites W2578798018 @default.
• W2912887446 cites W2588715825 @default.
• W2912887446 cites W2701604424 @default.
• W2912887446 cites W2728117782 @default.
• W2912887446 cites W2774674623 @default.
• W2912887446 cites W4255931893 @default.
• W2912887446 doi "https://doi.org/10.3851/imp3297" @default.
• W2912887446 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30747107" @default.
• W2912887446 hasPublicationYear "2018" @default.
• W2912887446 type Work @default.
• W2912887446 sameAs 2912887446 @default.
• W2912887446 citedByCount "6" @default.
• W2912887446 countsByYear W29128874462019 @default.
• W2912887446 countsByYear W29128874462020 @default.
• W2912887446 countsByYear W29128874462021 @default.
• W2912887446 countsByYear W29128874462022 @default.
• W2912887446 countsByYear W29128874462023 @default.
• W2912887446 crossrefType "journal-article" @default.
• W2912887446 hasAuthorship W2912887446A5010962818 @default.
• W2912887446 hasAuthorship W2912887446A5011056386 @default.
• W2912887446 hasAuthorship W2912887446A5019618541 @default.
• W2912887446 hasAuthorship W2912887446A5029391761 @default.
• W2912887446 hasAuthorship W2912887446A5036522089 @default.
• W2912887446 hasAuthorship W2912887446A5041849450 @default.
• W2912887446 hasAuthorship W2912887446A5060181762 @default.
• W2912887446 hasAuthorship W2912887446A5064873706 @default.
• W2912887446 hasAuthorship W2912887446A5081346347 @default.
• W2912887446 hasConcept C126322002 @default.
• W2912887446 hasConcept C142462285 @default.
• W2912887446 hasConcept C159047783 @default.
• W2912887446 hasConcept C207103383 @default.
• W2912887446 hasConcept C2522874641 @default.
• W2912887446 hasConcept C2777068322 @default.
• W2912887446 hasConcept C2777869810 @default.
• W2912887446 hasConcept C2778723075 @default.
• W2912887446 hasConcept C2779182219 @default.
• W2912887446 hasConcept C2779298103 @default.
• W2912887446 hasConcept C2779465607 @default.
• W2912887446 hasConcept C2779502633 @default.
• W2912887446 hasConcept C2779778239 @default.
• W2912887446 hasConcept C2780404665 @default.
• W2912887446 hasConcept C2780524789 @default.
• W2912887446 hasConcept C2780593183 @default.
• W2912887446 hasConcept C2781413609 @default.
• W2912887446 hasConcept C2781432083 @default.
• W2912887446 hasConcept C2911190787 @default.
• W2912887446 hasConcept C2993143319 @default.
• W2912887446 hasConcept C3013748606 @default.
• W2912887446 hasConcept C44249647 @default.
• W2912887446 hasConcept C71924100 @default.
• W2912887446 hasConceptScore W2912887446C126322002 @default.
• W2912887446 hasConceptScore W2912887446C142462285 @default.
• W2912887446 hasConceptScore W2912887446C159047783 @default.
• W2912887446 hasConceptScore W2912887446C207103383 @default.
• W2912887446 hasConceptScore W2912887446C2522874641 @default.
• W2912887446 hasConceptScore W2912887446C2777068322 @default.
• W2912887446 hasConceptScore W2912887446C2777869810 @default.
• W2912887446 hasConceptScore W2912887446C2778723075 @default.
• W2912887446 hasConceptScore W2912887446C2779182219 @default.
• W2912887446 hasConceptScore W2912887446C2779298103 @default.
• W2912887446 hasConceptScore W2912887446C2779465607 @default.
• W2912887446 hasConceptScore W2912887446C2779502633 @default.
• W2912887446 hasConceptScore W2912887446C2779778239 @default.
• W2912887446 hasConceptScore W2912887446C2780404665 @default.
• W2912887446 hasConceptScore W2912887446C2780524789 @default.
• W2912887446 hasConceptScore W2912887446C2780593183 @default.
• W2912887446 hasConceptScore W2912887446C2781413609 @default.
• W2912887446 hasConceptScore W2912887446C2781432083 @default.
• W2912887446 hasConceptScore W2912887446C2911190787 @default.
• W2912887446 hasConceptScore W2912887446C2993143319 @default.

• next